Tumor Immune Microenvironment

The tumor immune microenvironment (TIME) is composed of hetereogenous immune cells that have infiltrated the tumor, and is a central target of cancer immunotherapies. Characterization of the TIME is key to predicting response and development of immunotherapy. Discover the latest research here.

September 15, 2020

A New Drug Testing Platform Based on 3D Tri-culture in Lab-on-a-chip Devices

European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
Begum GokceDevrim Pesen Okvur
May 21, 2020
Open Access

The immune microenvironment in typical carcinoid lung tumour, a brief report of four cases

Scandinavian Journal of Immunology
Branislava StankovicAlexandre Corthay
June 25, 2020
Review

Iron in the Tumor Microenvironment

Advances in Experimental Medicine and Biology
Driton Vela
August 18, 2020
Open Access

Targeting Prostate Cancer Using Intratumoral Cytotopically Modified Interleukin-15 Immunotherapy in a Syngeneic Murine Model

ImmunoTargets and Therapy
Efthymia PapaevangelouChristine Galustian
September 1, 2020

Development of programmed death receptor-1 and programmed death receptor-1 ligand in oral squamous cell carcinoma

Hua xi kou qiang yi xue za zhi = Huaxi kouqiang yixue zazhi = West China journal of stomatology
Zhi-Hong Chen, Ya-Dong Wu
June 25, 2020
Review

Extracellular Vesicles in the Tumor Microenvironment: Various Implications in Tumor Progression

Advances in Experimental Medicine and Biology
Alex C BoomgardenCrislyn D'Souza-Schorey
June 6, 2020
Review

Pro-tumorigenic functions of macrophages at the primary, invasive and metastatic tumor site

Cancer Immunology, Immunotherapy : CII
Elaheh NasrollahzadehNima Rezaei
May 29, 2020
Review
Open Access

Immune checkpoint pathways in immunotherapy for head and neck squamous cell carcinoma

International Journal of Oral Science
Zi MeiAlfred King-Yin Lam
July 31, 2020
Open Access

Mutant KRAS Promotes NKG2D+ T Cell Infiltration and CD155 Dependent Immune Evasion

Anticancer Research
Kensuke NishiToshiyuki Tsunoda
June 27, 2020
Review

Chimeric Antigen Receptors for the Tumour Microenvironment

Advances in Experimental Medicine and Biology
Rosemary HabibKavitha Gowrishankar
July 18, 2020

Tumor-initiating cells establish an IL-33-TGF-β niche signaling loop to promote cancer progression

Science
Sachiko TaniguchiNaoki Oshimori
July 15, 2020

Strategies and challenges of immunotherapy for hepatocellular carcinoma

Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology
H H Zhang, H S Chen
May 22, 2020
Open Access

Spatial immune profiling of the colorectal tumor microenvironment predicts good outcome in stage II patients

NPJ Digital Medicine
Ines P NearchouPeter D Caie
June 13, 2020
Review
Open Access

Killing the "BAD": Challenges for immunotherapy in pancreatic cancer

Biochimica Et Biophysica Acta. Reviews on Cancer
Tian-Jiao LiLiang Liu
August 21, 2020
Open Access

An immune evasion mechanism with IgG4 playing an essential role in cancer and implication for immunotherapy

Journal for Immunotherapy of Cancer
Hui WangJiang Gu
June 9, 2020

In vivo characterization of PD-L1 expression in breast cancer by immuno-PET with 89 Zr-labeled avelumab

American Journal of Translational Research
Miao LiWeibo Cai

Sign up to follow this feed and discover related papers.

Related Feeds

Antibody Engineering

Antibody engineering technologies are constantly advancing to improve the clinical effectiveness of monoclonal and bispecific antibodies. Discover the latest research on Antibody Engineering here.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Autophagy & Metabolism

Autophagy preserves the health of cells and tissues by replacing outdated and damaged cellular components with fresh ones. In starvation, it provides an internal source of nutrients for energy generation and, thus, survival. A powerful promoter of metabolic homeostasis at both the cellular and whole-animal level, autophagy prevents degenerative diseases. It does have a downside, however--cancer cells exploit it to survive in nutrient-poor tumors.

Autophagy: Cancer & Parkinson

Autophagy leads to degradation of damaged proteins and organelles by the lysosome. Impaired autophagy has been implicated in several diseases. Here is the role of autophagy in cancer and Parkinson’s.

Biophysics of Adhesion

Alterations in cell adhesion can disrupt important cellular processes and lead to a variety of diseases, including cancer and arthritis. It is also essential for infectious organisms, such as bacteria or viruses, to cause diseases. Understanding the biophysics of cell adhesion can help understand these diseases. Discover the latest research on the biophysics of adhesion here.

Cancer Biology: Molecular Imaging

Molecular imaging enables noninvasive imaging of key molecules that are crucial to tumor biology. Discover the latest research in molecular imaging in cancer biology in this feed.

Cancer Imaging

Imaging techniques, including CT and MR, have become essential to tumor detection, diagnosis, and monitoring. Here is the latest research on cancer imaging.

Cancer Metabolism

In order for cancer cells to maintain rapid, uncontrolled cell proliferation, they must acquire a source of energy. Cancer cells acquire metabolic energy from their surrounding environment and utilize the host cell nutrients to do so. Here is the latest research on cancer metabolism.

Cell Migration in Cancer and Metastasis

Migration of cancer cells into surrounding tissue and the vasculature is an initial step in tumor metastasis. Discover the latest research on cell migration in cancer and metastasis here.

Cell Signaling by Tyrosine Kinases

Receptor tyrosine kinases (RTKs) are the high-affinity cell surface receptors for many polypeptide growth factors, cytokines, and hormones. RTKs have been shown not only to be key regulators of normal cellular processes but also to have a critical role in the development and progression of many types of cancer. Discover the latest research on cell signaling and RTK here.

© 2020 Meta ULC. All rights reserved
/feed-previews/tumor-immune-microenvironment/042f0036-f62b-4181-bfc9-3c68dfd80a58